🇺🇸 FDA
Patent

US 11471460

Autophagy modulators for use in treating cancer

granted A61KA61K31/506A61K31/53

Quick answer

US patent 11471460 (Autophagy modulators for use in treating cancer) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/506, A61K31/53, A61K31/5377, A61P